Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2001 to 2050 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1084\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7029.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6437.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylethanolamine-binding protein (pebp) (prostatic binding protein) (hcnppp) (neuropolypeptide h3) (raf kinase inhibitor protein) (rkip) [contains: hippocampal cholinergic neurostimulating peptide (hcnp)]. [source:swissprot;acc:p30086]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3162\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory alpha subunit (pi3-kinase p85-alpha subunit) (ptdins-3-kinase p85-alpha) (pi3k). [source:swissprot;acc:p27986]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
865\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory beta subunit (pi3-kinase p85-beta subunit) (ptdins-3-kinase p85-beta). [source:swissprot;acc:o00459]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
870\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory gamma subunit (pi3-kinase p85-gamma subunit) (ptdins-3-kinase p85-gamma) (p55pik). [source:swissprot;acc:q92569]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
867\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol glycan class t precursor. [source:refseq;acc:nm\_015937]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3024\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing beta polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-beta) (ptdins-3-kinase c2 beta) (pi3k-c2beta) (c2-pi3k). [source:swissprot;acc:o00750]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1701\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6762.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6326.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06892\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing gamma polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-gamma) (ptdins-3-kinase c2 gamma) (pi3k-c2gamma). [source:swissprot;acc:o75747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1700\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylinositol-binding clathrin assembly protein (clathrin assembly lymphoid myeloid leukemia protein). [source:swissprot;acc:q13492]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2290\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6048.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
586\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7644.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6739.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoacetylglucosamine mutase (ec 5.4.2.3) (pagm) (acetylglucosamine phosphomutase) (n-acetylglucosamine-phosphate mutase) (phosphoglucomutase 3). [source:swissprot;acc:o95394]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1603\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5605.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5232.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07142\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphofurin acidic cluster sorting protein 1 isoform 1; cytosolic sorting protein pacs-1. [source:refseq;acc:nm\_018026]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2805\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate kinase 1 (ec 2.7.2.3) (primer recognition protein 2) (prp 2). [source:swissprot;acc:p00558]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
946\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7241.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6598.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09744\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate kinase, testis specific (ec 2.7.2.3). [source:swissprot;acc:p07205]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
942\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7240.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1113\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1114\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoinositide-3-kinase, class 2, alpha polypeptide; c2-containing phosphatidylinositol kinase. [source:refseq;acc:nm\_002645]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6762.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6326.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06892\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoinositide-3-kinase, class 3; vps34; phosphatidylinositol 3-kinase, class 3. [source:refseq;acc:nm\_002647]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3173\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipase d1 (ec 3.1.4.4) (pld 1) (choline phosphatase 1) (phosphatidylcholine-hydrolyzing phospholipase d1) (hpld1). [source:swissprot;acc:q13393]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1622\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6589.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6153.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07081\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipase d2 (ec 3.1.4.4) (pld 2) (choline phosphatase 2) (phosphatidylcholine-hydrolyzing phospholipase d2) (pld1c) (hpld2). [source:swissprot;acc:o14939]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1626\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6591.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6157.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07055\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid scramblase 2 (pl scramblase 2) (ca(2+)-dependent phospholipid scramblase 2). [source:swissprot;acc:q9nry7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6685.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6260.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06783\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid scramblase 3 (pl scramblase 3) (ca(2+)-dependent phospholipid scramblase 3). [source:swissprot;acc:q9nry6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6684.31\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6259.8\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06782\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid scramblase 4 (pl scramblase 4) (ca(2+)-dependent phospholipid scramblase 4). [source:swissprot;acc:q9nrq2]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1730\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6684.3\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.06781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phospholipid transfer protein precursor (lipid transfer protein ii). [source:swissprot;acc:p55058]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2339\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5350.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5123.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04428\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1026\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6029.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5509.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09427\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1025\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6031.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5511.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoribosyl pyrophosphate synthetase-associated protein 1 (prpp synthetase-associated protein 1) (39 kda phosphoribosypyrophosphate synthetase-associated protein) (pap39). [source:swissprot;acc:q14558]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2869\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoribosyl pyrophosphate synthetase-associated protein 2 (prpp synthetase-associated protein 2) (41 kda phosphoribosypyrophosphate synthetase-associated protein) (pap41). [source:swissprot;acc:o60256]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2943\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoribosylformylglycinamidine synthase (ec 6.3.5.3) (fgam synthase) (fgams) (formylglycinamide ribotide amidotransferase) (fgarat) (formylglycinamide ribotide synthetase). [source:swissprot;acc:o15067]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2461\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5272.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5114.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03105\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pinch protein (particularly interesting new cys-his protein) (lim and senescent cell antigen-like domains 1). [source:swissprot;acc:p48059]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1868\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pinin, desmosome associated protein; pinin. [source:refseq;acc:nm\_002687]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1227\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6483.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5973.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
placenta growth factor precursor (plgf). [source:swissprot;acc:p49763]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3036\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
placental protein 11 precursor (ec 3.4.21.-) (pp11). [source:swissprot;acc:p21128]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3076\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2409\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
plasma carboxypeptidase b2 isoform a preproprotein; carboxypeptidase u; thrombin-activatable fibrinolysis inhibitor; carboxypeptidase b-like protein; thrombin-activable fibrinolysis inhibitor. [source:refseq;acc:nm\_001872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
241\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6265.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
plasminogen activator inhibitor-2 precursor (pai-2) (placental plasminogen activator inhibitor) (monocyte arg-serpin) (urokinase inhibitor). [source:swissprot;acc:p05120]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2407\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
platelet-activating factor acetylhydrolase ib alpha subunit (ec 3.1.1.47) (paf acetylhydrolase 45 kda subunit) (paf-ah 45 kda subunit) (paf-ah alpha) (pafah alpha) (lissencephaly-1 protein) (lis- 1). [source:swissprot;acc:p43034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3221\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pleckstrin homology domain containing, family c (with ferm domain) member 1; mitogen inducible 2; kindlin 2. [source:refseq;acc:nm\_006832]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1878\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
332\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5975.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5051.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.183\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
762\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6933.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6231.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11275\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
306\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11409.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13680.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.19903\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
pogo transposable element with znf domain isoform 1. [source:refseq;acc:nm\_015100]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2932\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly (adp-ribose) glycohydrolase. [source:refseq;acc:nm\_003631]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
840\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6395.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5786.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10526\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly(a) polymerase alpha (ec 2.7.7.19) (pap) (polynucleotide adenylyltransferase alpha) (fragment). [source:swissprot;acc:p51003]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
285\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19296.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23326.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
poly(a) polymerase gamma (ec 2.7.7.19) (pap gamma) (polynucleotide adenylyltransferase gamma) (srp rna 3' adenylating enzyme). [source:swissprot;acc:q9bwt3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
287\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
19279.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
23303.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 1 (poly(a)-binding protein 1) (pabp 1). [source:swissprot;acc:p11940]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1095\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6316.61\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5791.05\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09075\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1091\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1094\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
643\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5414.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4810.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12542\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/